Enlength®:Bortezomib for Injection

Enlength®:Bortezomib for Injection

Indications:

Used for the treatment of patients with multiple myeloma and mantle cell lymphoma.

As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatment of Multiple Myeloma in China and was included in the NDRL.